Trial Type: Myeloma

DFCI-IPDRRM
A Phase I/II Study of Twice Weekly Ixazomib Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma (2 or more lines of therapy)
Status: Open
Trial Type: Myeloma
Contact: Dr. John Reagan
jreagan@lifespan.org

©2023 Brown Cancer Clinical Trials